Blood Phoenixin-14 Levels and Echocardiographic Findings in Infants of Diabetic Mothers
Investigation of the Relationship Between Phoenixin-14 Levels and Echocardiographic Findings in Infants of Diabetic Mothers
Konya City Hospital
84 participants
Sep 1, 2024
INTERVENTIONAL
Conditions
Summary
In this study, the investigators hypothesize that echocardiographic pathologies observed in infants of diabetic mothers are associated with elevated serum phoenixin-14 levels.
Eligibility
Inclusion Criteria2
- Infants of diabetic mothers
- Healthy term infants
Exclusion Criteria2
- Infants whose families did not provide consent
- Infants with a syndromic appearance or congenital heart disease
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
For participants who provide consent, blood samples will be collected at 6 hours postpartum. Additionally, infants included in the study will undergo an echocardiographic evaluation by a pediatric cardiologist between postnatal days 3 and 5.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06891586